Hamdy Ahmed MD 4
4 · Vincerx Pharma, Inc. · Filed Dec 14, 2022
Insider Transaction Report
Form 4
Hamdy Ahmed MD
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2022-12-14$0.87/sh+35,280$30,538→ 73,760 total(indirect: By Trust)
Holdings
- 1,618,199
Common Stock
Footnotes (1)
- [F1]Represents a weighted average purchase price. Actual purchase prices ranged from $0.829 to $0.87 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.